Seattle, WA, United States of America

Jean-Rene E Ella-Menye

This inventor holds 1 USPTO granted patent. Top assignee: Genevant Sciences Gmbh. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Rene E Ella-Menye. Retrieved from https://idiyas.com/inventor/jean-rene-e-ella-menye

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jean-Rene E Ella-Menye

Introduction

Jean-Rene E Ella-Menye is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of branched peg molecules. His work has implications for therapeutic and diagnostic applications, showcasing his innovative spirit and dedication to advancing science.

Latest Patents

Jean-Rene E Ella-Menye holds a patent for "Branched peg molecules and related compositions and methods." This patent discloses branched PEG molecules, including branched PEG-lipids and branched-PEG proteins. It also covers related compositions and methods for making branched PEG molecules, as well as systems and methods for in vivo delivery of therapeutic and diagnostic agents. He has 1 patent to his name.

Career Highlights

Jean-Rene E Ella-Menye is currently associated with Genevant Sciences GmbH, where he continues to push the boundaries of innovation in biotechnology. His work at the company reflects his commitment to developing advanced solutions in the field.

Collaborations

Some of his notable coworkers include Debashish Roy and Sean D Monahan, who contribute to the collaborative environment that fosters innovation at Genevant Sciences GmbH.

Conclusion

Jean-Rene E Ella-Menye exemplifies the spirit of innovation in biotechnology through his patented work and collaborations. His contributions are paving the way for future advancements in therapeutic and diagnostic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…